Dextrofer-100 with B12 and dextrofer-100--comparative pharmacological and clinico-pharmacological studies

Dilov, P.; Antonov, S.; Chakŭrov, R.; Petkov, R.; Gabrovski, P.

Veterinarno-Meditsinski Nauki 21(6): 91-100

1984


ISSN/ISBN: 0324-1068
PMID: 6495646
Document Number: 5165
Comparative studies were carried out with dextrofer-100 with B12 and dextrofer-100 in terms of acute toxicity (albino mice), absorption (rabbits, pigs, and lambs), deposition of iron in the liver and spleen (rabbits, pigs, and lambs) and antianemic action (pigs and lambs). It was found that LD50 of dextrofer-100 with B12 at i/v introduction into 18-20-gram albino mice was 1750 mg Fe3+/kg body mass; with regard to toxicity it was shown to correspond to the British Veterinary Code. The toxicity of dextrofer-100, studied by the same test, was practically undeterminable. By the level of sideremia dextrofer-100 with B12 did not differ essentially from dextrofer-100 and was said to belong to preparations with rapid absorption. It was most rapidly absorbed in pigs, rabbits and lambs following next. It supplied enough iron to the reticuloendothelial organs--in pigs it was (on a percent basis) highest in the liver, and in lambs--in the spleen. In pigs on the 10th day following treatment with dextrofer-100 with B12 the liver was shown to have vitamin B12 5 times as much. By its antianemic effect at i/m application to newborn pigs and lambs dextrofer-100 with B12 did not differ essentially from dextrofer-100 (its action was negligibly broader), however, it was beneficial to the growth of pigs.

Document emailed within 1 workday
Secure & encrypted payments

Dextrofer-100 with B12 and dextrofer-100--comparative pharmacological and clinico-pharmacological studies